As JPM week drew to a close, Lilly CEO David Ricks discussed what he sees in store for the biopharma industry.
Tag Archive for: mergers
All three companies closed out the year, which saw significant growth in mergers and acquisitions, with high-value deals that could potentially set the tone for M&A in 2024.
Cigna is in merger talks with Humana a source familiar with the matter said on Wednesday, potentially marking the latest in a long string of deals aimed at consolidation of the industry.
The new guidelines mark a significant shift in the approach to examining mergers in the pharma industry. Previously, the federal government’s antitrust enforcers primarily focused on direct competition, but the updated guidelines now consider how companies leverage their negotiating power.
The layoffs are a result of Sumitomo’s decision announced in April to combine its seven subsidiaries into one company.
Blockbuster deals are on the rise as drug manufacturers navigate through patent cliffs, pricing pressures, and evolving regulations while M&A activity remains an integral part of the strategic landscape.
The top pharma companies in 2021 continued to be engaged in creating vaccines and therapeutics, and the investments in R&D led to greater revenue and earnings.
Plunging valuations have made biotech companies tempting acquisition targets for cash-rich Big Pharma and a flurry of deals is just what the battered sector needs to turn a corner.
For many in the biotech space, the pandemic was a chance to prove their worth, creating vaccines in record time and, for some, earning significant profits. Now, with the pandemic receding amidst rumblings of a global recession, the industry is facing what some consider the worst times since its inception.
March 14 marks the launch of Lumanity, a company dedicated to improving patient health by accelerating and optimizing access to medical advances.
